Page last updated: 2024-10-22

acetazolamide and Arteriosclerosis, Coronary

acetazolamide has been researched along with Arteriosclerosis, Coronary in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsikas, D1
Thum, T1
Becker, T1
Pham, VV1
Chobanyan, K1
Mitschke, A1
Beckmann, B1
Gutzki, FM1
Bauersachs, J1
Stichtenoth, DO1

Other Studies

1 other study available for acetazolamide and Arteriosclerosis, Coronary

ArticleYear
Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, May-15, Volume: 851, Issue:1-2

    Topics: Acetazolamide; Adult; Arginine; Benzamides; Circadian Rhythm; Coronary Artery Disease; Dimethylamine

2007